News and Trends 27 Jun 2023 UCB myasthenia gravis drug given FDA approval …receptor (AchR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive. Rozanolixizumab-noli injection for subcutaneous infusion is a humanized IgG4 monoclonal antibody that binds to the neonatal Fc receptor (FcRN), resulting in… June 27, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jul 2018 Swedish Alzheimer’s Treatment Slows the Disease in Phase II Trial BioArctic, based in Stockholm, has clinical results showing its antibody treatment that targets amyloid plaques, a hallmark of Alzheimer’s disease, can slow the disease’s progression. The trial tested the antibody… July 9, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jul 2020 Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal …cells. Kiadis’ cell therapy complements Sanofi’s antibody drugs “because it provides a way to deliver cancer-attacking natural killer cells to patients,” Lahr said. The antibody drugs that Sanofi will combine… July 13, 2020 - 3 minutesmins - By David Wilson Share WhatsApp Twitter Linkedin Email
Interview 19 Aug 2022 How re-engineering antibodies can prevent allergies …allowing us to identify the sequences of individual IgE antibodies. Once we have those sequences, we can start the re-engineering process. We retain the portion of the IgE antibody that… August 19, 2022 - 9 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
Interview 8 May 2017 Meet the co-developer of the first commercial mAb and gene therapy Sander van Deventer is now a managing partner at Forbion after playing a critical role in the development of the first commercial monoclonal antibody, Remicade, and the first market-approved gene… May 8, 2017 - 5 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
In Depth 22 Mar 2021 Can Immunotherapy Offer Hope for Parkinson’s Sufferers? …antibody binds,” said Wagner Zago, CSO of Prothena, which has its headquarters in Dublin. “We’ve learnt that to drive efficacy, it’s really important for the antibody to have a very… March 22, 2021 - 5 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
In Depth 5 Jun 2024 Evolving standards of care: new treatments for cervical cancer …came after the antibody drug conjugate showed overall survival (OS) benefit in patients who had previously been treated for cervical cancer. A 30% reduction in the risk of death compared… June 5, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 26 Feb 2018 This Multiple Sclerosis Drug Could Help to Fight Another Autoimmune Disease The FDA has awarded Orphan Drug Designation to GeNeuro’s antibody for the treatment of a rare autoimmune disease following promising Phase IIb results in multiple sclerosis patients. GeNeuro develops therapies… February 26, 2018 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 3 Sep 2025 How are biotechs tackling malaria? …making of the monoclonal antibody MAM01 along with the University of Maryland School of Medicine in the U.S. It is an engineered version of a human monoclonal antibody that is… September 3, 2025 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Interview 4 Sep 2017 Meet this Blockbuster Developer turned Partner at a Headlining VC Kevin Johnson told me the story and lessons of his career, from CTO of Cambridge Antibody Technology to General Partner at Medicxi. Since starting his biotech career as the lead… September 4, 2017 - 7 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 28 Sep 2022 Pheon Therapeutics launches with $68M in series A funding for treatment of solid tumors Pheon Therapeutics launched today (September 28) following the closing of a $68 million series A funding back in March. The investment will allow antibody-drug conjugate (ADC) specialist Pheon to advance… September 28, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2025 The ESMO 2025 digest: Is oncology in good shape? The European Society for Medical Oncology(ESMO) Congress 2025 in Berlin (17–21 October) delivered a week of consequential but not always uniform readouts. Antibody-drug conjugates (ADCs) stayed in the spotlight, most notably with disitamab vedotin… October 24, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email